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2) It is used in traditional Indian medicine, the Ayurveda, for the treatment of anxiety, and in improving intellect and memory for several centuries. 3) In addition to memory boosting activity, it is also claimed to be useful in the treatment of cardiac, respiratory 4) and neuropharmacological 5) disorders like insomnia, insanity, depression, psychosis, epilepsy and stress. It was reported to possess anti-inflammatory, analgesic, antipyretic, sedative 6) free radical scavenging and anti-lipid peroxidative activities 7) also. The pharmacological properties 8) of Bacopa monnieri were studied extensively and the activities were attributed mainly due to the presence of characteristic saponins called as "bacosides." Bacosides are complex mixture of structurally closely related compounds, glycosides of either jujubogenin or pseudojujubogenin (Fig. 1) . Bacosides have been found to offer protective role in the synaptic functions of the nerves in hippocampus. 6) There are few methods reported in the literature for quantification of bacosides in plant extracts and formulations. Spectrophotometric methods 9, 10) developed based on the hydrolysis of bacosides to an aglycone that has an absorption maximum at 278 nm. The major limitation of this method is that it lacks specificity and has interference from other hydrolyzed compounds. A high performance thin-layer chromatographic (HPTLC) 11) method was developed for the estimation of bacoside A in Bacopa monnieri plant and its formulations. A few high performance liquid chromatographic (HPLC) [12] [13] [14] [15] [16] methods were also developed for the quantification of bacosides in Bacopa monnieri extracts and formulations. Ganzera et al. 15) reported the method for quantification of six saponins using gradient HPLC with PDA detector, but one of the major peaks was not completely characterized. Deepak et al. 16) determined bacoside A which contains 4 compounds by HPLC, but did not consider bacoside B. In another report, bacosides were estimated by HPLC, coupled NMR, MS and bioassay methods described. 14) As the number of aged people suffering from cognitive problems increases the memory boosters have gained immense importance and there is an urgent need to develop sensitive and reliable quality control techniques to establish the authenticity and purity of memory boosting formulations. The value of the method increases with the estimation of all the characteristic compounds present in the extracts because the major components could be present in several closely related species. In the present study, a simple reversed phase HPLC method was developed and validated for separation and simultaneous quantification of all the 12 bacopa saponins in Bacopa monnieri plant, extracts and commercial formulations.
Experimental
Materials Compounds 1-12 were kindly provided by phytochemistry division of Laila Research Centre Vijayawada, India. Identity and purity (Ͼ95%) of the isolated compounds were confirmed by chromatographic (TLC, HPLC) and spectral (IR, Mass and NMR) data. [17] [18] [19] [20] [21] [22] [23] [24] Bacopa monnieri plant materials, extracts analyzed in this study were supplied by M/s Laila Impex, Vijayawada, India and commercial formulations containing Bacopa monnieri were procured from the local market and Australia. Methanol and acetonitrile (HPLC grade), sodium sulphate and sulphuric acid (analytical grade) were purchased from Qualigens (Mumbai, India). Ultrapure water generated by the Barnstead nanopure system (Model D3750, U.S.A.) was used. Seventy percent (v/v) methanol in water was used as solvent for extraction of Bacopa monnieri plant materials. Sodium sulphate (0.05 M) prepared in water and adjusted to pH 2.3 with dilute sulphuric acid using Elico pH meter (model LI 120). Sulphate buffer (pH 2.3) and acetonitrile (68.5 : 31.5, v/v) was used as mobile phase. Sulphate buffer (pH 2.3) and acetonitrile (50 : 50, v/v) were used as a medium for preparation of extracts and commercial formulations. All solutions were filtered through 0.45 mm pore size membrane filter using a Millipore Swinnex type filtration unit.
Sample Preparation. Bacopa monnieri Plant Material One to five grams of Bacopa monnieri powdered plant material was weighed into a 100 ml round bottom flask, added about 30 ml of 70% (v/v) methanol and refluxed on a water bath for 30 min. Filtered and the extraction was repeated twice (2ϫ30 ml) with 70% (v/v) methanol, combined all the alcoholic frac-tions and made up to 100 ml with 70% (v/v) methanol and filtered through 0.45 mm membrane filter.
Bacopa monnieri Extracts Five hundred milligrams of the sample was dissolved in a medium of sodium sulphate (0.05 M) buffer pH 2.3 and acetonitrile (50 : 50, v/v), sonicated for 10 min, diluted to 100 ml with the same medium and filtered through 0.45 mm membrane filter.
Commercial Formulations The average weight of the capsule/tablet was determined by weighing 20 capsules/tablets. In case of capsules, hard gelatin shells were removed and finely powdered. Fifty milligrams of the finely powdered samples were dissolved in a medium of sodium sulphate (0.05 M) buffer pH 2.3 and acetonitrile (50 : 50, v/v), sonicated for 10 min and made up to 10 ml with the same medium and filtered through 0.45 mm membrane filter.
Calibration Standard solutions containing 10 mg/ml of the standards, 1-12, in a medium of sodium sulphate (0.05 M) buffer pH 2.3 and acetonitrile (50 : 50, v/v) (Stock solution). Six additional calibration levels were prepared by diluting stock solutions with the same medium in the range of 1.0-60.0 mg/20 ml ( Table 1 ). The standard curves were obtained using the peak areas of six different concentrations in six replicate assays and were expressed by the linear least square regression equation.
HPLC Instrumentation HPLC experiments were performed on a Shimadzu HPLC system equipped with Phenomenex Luna C 18 , 5 mm (4.6ϫ250 mm) column, LC10AT VP pumps, SCL-10AVP system controller, SIL-10 AD VP auto injector, SPD-M10 AVP photodiode array detector and class VP software was used.
Analytical Method In this method, the mobile phase was a mixture of 0.05 M sodium sulphate buffer pH 2.3 and acetonitrile (68.5 : 31.5, v/v) at flow rate of 1 ml/min and the column temperature was maintained at 30°C. The detection wave length was set at 205 nm. The injection volume was 20 ml. The chromatography system was equilibrated by the mobile phase. The separation and quantification of the samples was conducted when the same retention time and peak areas of the repetitive injection of the standard solutions were obtained. The total run time was 75 min.
Method Validation The specificity of the method was ascertained by analyzing the standards and the samples. The peaks for compounds 1-12 in the samples were confirmed by comparing the retention times of the peak with that of standards.
The linearity of the method was checked with standards 1-12 with the calibration curves in the range 1.0-60.0 mg/20 ml, using six different concentrations in six replicate assays. Limit of detection (LOD) and limit of quantification (LOQ) were obtained from the standard deviation (s) of the blank response (nϭ6) and slope (S) of the calibration curve using the formulae 3.3s/S and 10s/S, respectively.
Accuracy was determined by spiking pre-analyzed sample with low, medium and high concentrations in the calibration range of the standard compounds 1-12 and analyzed by the proposed method. The experiment was conducted six times to check the recovery of the analyte at different levels in the formulations.
Precision (intra-and inter-day) of the assay was verified by analyzing samples PM-1, PM-2 and PM-3. Six assays were carried out on each sample on the same day and on different days. Repeatability was confirmed by relative standard deviation (RSD%) of compounds (1-12), estimated in three samples.
Results and Discussion
A simple method was developed for the estimation of bacopasaponins 1-12 based on reversed phase HPLC separation combined with UV detection. An isocratic system was chosen to minimize the variations of the base line and also considering simplicity, precision and accuracy. The stability of the sample and standards 1-12 were checked and found to be stable for 48 h. An extraction procedure for plant materials was evaluated by extracting the plant material (PM-1) with 3ϫ30 ml of 70% methanol, which is sufficient for complete extraction of bacopa saponins 1-12.
Major saponins found in Bacopa monnieri are derivatives of two aglycones, jujubogenin and pseudojujubogenin (Fig.  1) . The saponins, in two groups, differ only in their sugar moieties. Bacopasaponins possess a weak chromophore. Separation of compounds 1-12 was difficult and required a careful assessment of all separation parameters like stationary phase and elution conditions. HPLC columns differing in stationary phase, pore size were initially screened for their potential to resolve the compounds 1-12. Special attention was paid to separation efficiency, peak shape and separation time. Best results were obtained with Luna C 18 column 5 mm particle size, 250 mm length and 4.6 mm i.d (Phenomenex) sodium sulphate (0.05 M) buffer pH 2.3 and acetonitrile (68.5 : 31.5, v/v) was used as mobile phase with 1 ml/min flow rate enabling the base line separation of all compounds within 75 min. All the separations were performed at 30°C. Absorption measurement at 205 nm was selected and the compounds 1-12 were effectively detected (Fig. 2) .
Validation of the Assay Method Method for the quanti- tative analysis of compounds 1-12 was validated with regard to its specificity, linearity, accuracy and precision by utilizing the ICH guidelines. 25) The specificity of the method was confirmed by reliability of compound peaks corresponding to compounds 1-12 in the sample. Bacopa monnieri sample was spiked with the compounds 1-12, individually, were separated by mobile phase sodium sulphate (0.05 M) buffer pH 2.3 and acetonitrile (68.5 : 31.5, v/v). The peak areas of the compounds 1-12 in the sample were changed consistently with their corresponding standards. The study confirmed the stable retention times of the compounds 1-12 in the samples were comparable with retention times of standard compounds 1-12 with Ϯ0.2 to Ϯ0.3 min variation (Table 1) .
The linearity of the method was checked with standards corresponding to 1-12 with the calibration curves in the concentration range 1.0-60.0 mg/20 ml. The regression equation and correlation coefficients were obtained with six replicate analyses for each concentration. The results of linearity data was reported in Table 1 shows that the correlation coefficient of the equations were Ͼ0.99 and the 12 calibration curves yielded straight lines in a wide range.
The limit of detection (LOD) of compounds 1-12 were in the range of 0.010-0.040 mg per injection and the limit of quantification (LOQ) of 1-12 were in the range 0.030- Where yϭ peak area, xϭconcentration of the compound mg/20 ml. 0.124 mg per injection ( Table 1) . Accuracy of the analytical method was determined by spiking sample with known amounts of 1-12 at three concentration levels. Due to the low amounts of standard compounds 6, 10 and 11 available, recovery was determined at middle concentration level only. The samples were analyzed under optimized conditions and the recovery rates were observed in the range 94.06 to 100.86% ( Table 2) .
The precision of the method was validated by both intraand inter-day variations. To determine intra-day variation six assays were carried out on same sample at different times during the day and inter-day variation was determined by analyzing on next day. Precision of the assay was verified by analyzing samples PM-1, PM-2 and PM-3 and found the percent relative standard deviation (RSD%) of intra-and interday variation was in the range of 0.11-8.50% for all compounds (Table 3) .
Application of the Method The method developed was applied to analyze three different Bacopa monnieri plant materials (PM), two different extracts (EM) and six different commercial formulations (FM), which were procured from domestic market and Australia. The results presented in Table 4 reveal that the compounds Bacoside A 3 (3), Bacopaside II (4), Bacopaside I (5), Bacopaside X (6) and Bacopasaponin C (7) were major components and the remaining were minor, but, in quantifiable amounts in Bacopa monnieri plant materials (PM) and total saponins are in the range 5.1-6.0%. Compounds 3-12 were the major peaks whereas Bacopasaponin F (1) and Bacopasaponin E (2) have been detected as minor components in Bacopa monnieri ex- tracts (EM). Major part of the saponin content was contributed by compounds 3-10 in all commercial formulations analyzed. Bacopaside IV (11) and Bacopaside V (12) were not present in commercial formulations (FM-1 and FM-2) procured in the domestic market. The total saponin content of the formulations are in the range 1.47-66.03 mg per capsule or tablet. The total saponin content was relatively less in formulations procured from domestic market (FM-1 and FM-2) in comparison with formulations procured from Australia. The presence of the herbal extracts of Withania somnifera, Nardostachys jatamansi, Ginko biloba, Panax ginseng and Capsicum annum, Vitamin B-Complex viz. thiamine HCl, riboflavine, pyridoxine HCl, niacinamide does not interfere in the estimation of bacosides 1-12 in commercial formulations. As such, the method may be applicable for polyherbal formulations also.
Conclusions
It was established from the pharmacological studies that bacosaponins were responsible for the biological activity of Bacopa monnieri. A simple reversed phase HPLC method has been developed for the simultaneous determination of all 12 bacopa saponins. The results demonstrate that the method developed was highly specific, accurate and precise and it could be used in the quality control of Bacopa monnieri extracts and formulations like tablets and capsules.
